EIR Amphastar Pharmaceuticals Feb 2004

Caryn Mcnab FDA$595.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observation (via FDA 483) on 03 Feb 2004.

Product details

  • Category:
  • Inspection end: 03 Feb 2004
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart